Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1985 1
1988 1
1990 1
1994 1
1995 2
1997 8
1998 3
1999 3
2000 3
2001 5
2002 2
2003 1
2004 4
2005 1
2006 3
2007 5
2008 2
2009 2
2010 1
2011 4
2012 2
2013 1
2014 2
2015 1
2016 1
2017 3
2018 5
2019 11
2020 13
2021 9
2022 7
2023 14
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

110 results

Results by year

Filters applied: . Clear all
Page 1
MDMA-assisted therapy for severe PTSD: a randomized, double-blind, placebo-controlled phase 3 study.
Mitchell JM, Bogenschutz M, Lilienstein A, Harrison C, Kleiman S, Parker-Guilbert K, Ot'alora G M, Garas W, Paleos C, Gorman I, Nicholas C, Mithoefer M, Carlin S, Poulter B, Mithoefer A, Quevedo S, Wells G, Klaire SS, van der Kolk B, Tzarfaty K, Amiaz R, Worthy R, Shannon S, Woolley JD, Marta C, Gelfand Y, Hapke E, Amar S, Wallach Y, Brown R, Hamilton S, Wang JB, Coker A, Matthews R, de Boer A, Yazar-Klosinski B, Emerson A, Doblin R. Mitchell JM, et al. Among authors: gelfand y. Nat Med. 2021 Jun;27(6):1025-1033. doi: 10.1038/s41591-021-01336-3. Epub 2021 May 10. Nat Med. 2021. PMID: 33972795 Free PMC article. Clinical Trial.
MDMA-assisted therapy for moderate to severe PTSD: a randomized, placebo-controlled phase 3 trial.
Mitchell JM, Ot'alora G M, van der Kolk B, Shannon S, Bogenschutz M, Gelfand Y, Paleos C, Nicholas CR, Quevedo S, Balliett B, Hamilton S, Mithoefer M, Kleiman S, Parker-Guilbert K, Tzarfaty K, Harrison C, de Boer A, Doblin R, Yazar-Klosinski B; MAPP2 Study Collaborator Group. Mitchell JM, et al. Among authors: gelfand y. Nat Med. 2023 Oct;29(10):2473-2480. doi: 10.1038/s41591-023-02565-4. Epub 2023 Sep 14. Nat Med. 2023. PMID: 37709999 Free PMC article. Clinical Trial.
MDMA-Assisted Therapy for Severe PTSD: A Randomized, Double-Blind, Placebo-Controlled Phase 3 Study.
Mitchell JM, Bogenschutz M, Lilienstein A, Harrison C, Kleiman S, Parker-Guilbert K, Ot'alora G M, Garas W, Paleos C, Gorman I, Nicholas C, Mithoefer M, Carlin S, Poulter B, Mithoefer A, Quevedo S, Wells G, Klaire SS, van der Kolk B, Tzarfaty K, Amiaz R, Worthy R, Shannon S, Woolley JD, Marta C, Gelfand Y, Hapke E, Amar S, Wallach Y, Brown R, Hamilton S, Wang JB, Coker A, Matthews R, de Boer A, Yazar-Klosinski B, Emerson A, Doblin R. Mitchell JM, et al. Among authors: gelfand y. Focus (Am Psychiatr Publ). 2023 Jul;21(3):315-328. doi: 10.1176/appi.focus.23021011. Epub 2023 Jun 28. Focus (Am Psychiatr Publ). 2023. PMID: 37404971
Gene therapy for psychiatric disorders.
Gelfand Y, Kaplitt MG. Gelfand Y, et al. World Neurosurg. 2013 Sep-Oct;80(3-4):S32.e11-8. doi: 10.1016/j.wneu.2012.12.028. Epub 2012 Dec 23. World Neurosurg. 2013. PMID: 23268195 Review.
Imaging score for differentiation of meningioma grade.
Funari A, De la Garza Ramos R, Cezayirli P, Gelfand Y, Longo M, Ahmad S, Rahman S, Boyke AE, Levitt A, Hsu K, Agarwal V. Funari A, et al. Among authors: gelfand y. Neuroradiology. 2023 Mar;65(3):453-462. doi: 10.1007/s00234-022-03101-w. Epub 2022 Dec 12. Neuroradiology. 2023. PMID: 36504373
Predictors of mortality in chronic subdural hematoma evacuation.
Sayed R, Gross S, Zamarud A, Nie L, Mudhar G, Eikermann M, Rupp S, Kim J, Babar M, Basam M, Yassari R, Gelfand Y. Sayed R, et al. Among authors: gelfand y. Neurosurg Rev. 2023 Dec 1;46(1):318. doi: 10.1007/s10143-023-02213-y. Neurosurg Rev. 2023. PMID: 38036800
110 results